MIRA NASDAQ
MIRA Pharmaceuticals, Inc.
1W: -18.9%
1M: -14.1%
3M: -23.5%
YTD: -51.0%
1Y: -44.7%
3Y: -84.3%
$0.73
+0.01 (+0.98%)
Weekly Expected Move ±11.8%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships10
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2023-08-07
Earliest Filing
2025-09-30
Latest Filing
acquirer: 4
target: 3
licensee: 2
partner: 1
Counterparties (Filed by MIRA)
10 relationshipsCompanies named in MIRA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| MIRA Pharmaceuticals, Inc. | MIRA | acquirer | Parent company of Merger Sub acquiring SKNY in a merger transaction. | 2025-09-30 | View |
| MIRAPHARM Acquisition, Inc. | — | acquirer | Wholly owned subsidiary of MIRA Pharmaceuticals, Inc. used as the merger vehicle. | 2025-09-30 | View |
| SKNY Pharmaceuticals, Inc. | — | target | Target company being merged with and into Merger Sub. | 2025-09-30 | View |
| MIRA Pharmaceuticals, Inc. | MIRA | acquirer | Acquiring SKNY through a stock exchange and cash contribution | 2025-03-24 | View |
| SKNY Pharmaceuticals, Inc. | — | target | Target company being acquired by MIRA | 2025-03-24 | View |
| MIRALOGX LLC | — | licensee | Licensor of intellectual property for antidepressant compounds and M209/KETAMIR-2 | 2023-11-20 | View |
| MIRA PHARMACEUTICALS, INC. | MIRA | licensee | Licensee developing MIRA1a and M209/KETAMIR-2 for anxiety, cognitive decline, and neuropathic pain | 2023-11-20 | View |
| MIRA PHARMACEUTICALS, INC. | MIRA | target | Company issuing shares in an underwriting agreement | 2023-08-07 | View |
| KINGSWOOD INVESTMENTS | — | acquirer | Representative of the several underwriters | 2023-08-07 | View |
| KINGSWOOD CAPITAL PARTNERS, LLC | — | partner | Parent entity of Kingswood Investments | 2023-08-07 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-17 | Regulation FD; Exhibits | View | |
| 2026-09-16 | Shareholder Vote; Exhibits | View | |
| 2026-09-01 | Regulation FD; Exhibits | View | |
| 2026-08-06 | Regulation FD; Exhibits | View | |
| 2026-07-31 | Delisting Notice | View | |
| 2026-07-10 | Regulation FD; Exhibits | View | |
| 2026-07-06 | Regulation FD; Exhibits | View | |
| 2026-06-25 | Regulation FD; Exhibits | View | |
| 2026-06-17 | Regulation FD; Exhibits | View | |
| 2026-06-08 | Officer/Director Change; Exhibits | View | |
| 2026-06-04 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-05-27 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-05-13 | Other Events | View | |
| 2026-05-13 | Regulation FD | View | |
| 2026-03-23 | Other Events | View | |
| 2026-03-03 | Other Events | View | |
| 2026-02-02 | Other Events | View | |
| 2025-12-22 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-05 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-23 | Other Events | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR